Sees strong double digit worldwide Cardiac Ablation Solutions growth in Q3. Says expects surgical to return to more normalized growth in in Q3. Says expects sequential gross margin improvements in Q3 and Q4. Says on track to deliver high-single-digit reported EPS growth in second half. Comments and guidance taken from Q2 earnings conference call.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MDT:
- Options Volatility and Implied Earnings Moves Today, November 19, 2024
- Medtronic raises FY25 adjusted EPS view to $5.44-$5.50 from $5.42-$5.50
- Medtronic reports Q2 EPS $1.26, consensus $1.25
- Notable companies reporting before tomorrow’s open
- Options Volatility and Implied Earnings Moves This Week, November 18 – November 21, 2024